Afya Limited logo

Afya Limited

AFYA

NASDAQConsumer DefensiveEducation & Training Services

Regular session

$14.4394

+$0.1094 · +0.76%

Aug 24, 10:09 AM ET

AFYA company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Buy

Favorable setup — positive multi-factor alignment

Valuation

95

Deep Value

Momentum

44

Neutral

Sentiment

52

Mixed

Risk resilience

74

Moderate Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Afya Limited, operating through its subsidiaries, is a prominent medical education provider in Brazil. The company delivers a comprehensive array of educational products and services primarily focused on the medical field, encompassing medical schools, preparatory courses for medical residency, advanced graduate studies, and various other programs tailored for medical professionals at all career stages. These offerings are available across its proprietary network and are also extended to external medical institutions. Beyond traditional education, Afya also offers digital health services through a subscription-based platform, accessible via a mobile app and website. This platform is specifically designed to assist healthcare practitioners and students with clinical decision-making by providing essential tools such as medical calculators, reference charts, up-to-date content, prescription guidance, clinical scoring systems, details on medical procedures, and laboratory examination information. While strong in medicine, Afya's educational portfolio spans a broader spectrum of health sciences, including dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine. Furthermore, the company extends its academic offerings beyond healthcare to include undergraduate and postgraduate degree programs in diverse subjects like business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. The company further enhances its educational ecosystem by providing specialized postgraduate medical programs, both printed and digital educational materials, an online medical learning platform, and hands-on medical training opportunities. As of December 31, 2021, Afya maintained an extensive network of 46 undergraduate and graduate medical school campuses, which included 30 operational undergraduate units and five approved units. This infrastructure supported a total capacity of 2,731 medical school seats, with 2,481 actively operating and an additional 278 seats approved for future use. Established in 1999, Afya Limited is headquartered in Nova Lima, Brazil.

Industry
Education & Training Services
Sector
Consumer Defensive
Headquarters
BR
CEO
Virgilio Deloy Capobianco Gibbon
Listed since
Jul 19, 2019
Employees
9,395

Market position

Day range

Current $14.4394

52-week range

Current $14.4394

Open
$14.33
Previous close
$14.33
Volume
22.57K
0.23× average
Average volume
98.62K
Average daily volume
Market cap
1.3B USD
Beta
0.38
Market reference 1
50-day average
$14.1882
+1.77% above average
200-day average
$14.4659
-0.18% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

P/E (TTM)
8.51×
P/B (TTM)
1.35×
P/S (TTM)
1.75×
Dividend yield
4.55%

Profitability & efficiency

Gross margin
63.98%
Operating margin
32.22%
Net margin
20.41%

Financial health

Debt / equity
0.64×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends70%49%28%8%Gross margin, FY2021: 62.06%Gross margin, FY2022: 63.09%Gross margin, FY2023: 61.41%Gross margin, FY2024: 63.21%Gross margin, FY2025: 64.46%Operating margin, FY2021: 25.64%Operating margin, FY2022: 28.51%Operating margin, FY2023: 26.67%Operating margin, FY2024: 30.63%Operating margin, FY2025: 32.81%Net margin, FY2021: 12.99%Net margin, FY2022: 16.04%Net margin, FY2023: 13.43%Net margin, FY2024: 19.11%Net margin, FY2025: 20.35%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 62.06%. Gross margin FY2022 63.09%. Gross margin FY2023 61.41%. Gross margin FY2024 63.21%. Gross margin FY2025 64.46%. Operating margin FY2021 25.64%. Operating margin FY2022 28.51%. Operating margin FY2023 26.67%. Operating margin FY2024 30.63%. Operating margin FY2025 32.81%. Net margin FY2021 12.99%. Net margin FY2022 16.04%. Net margin FY2023 13.43%. Net margin FY2024 19.11%. Net margin FY2025 20.35%.

Income trends

Revenue

3.62B USD+9.69%

Operating income

1.19B USD+17.51%

Net income

737.68M USD+16.81%
Income trends across reported periods3.96B USD2.6B USD1.24B USD−116.8M USDRevenue, FY2021: 1.72B USDRevenue, FY2022: 2.33B USDRevenue, FY2023: 2.88B USDRevenue, FY2024: 3.3B USDRevenue, FY2025: 3.62B USDOperating income, FY2021: 440.9M USDOperating income, FY2022: 664.1M USDOperating income, FY2023: 767.06M USDOperating income, FY2024: 1.01B USDOperating income, FY2025: 1.19B USDNet income, FY2021: 223.33M USDNet income, FY2022: 373.57M USDNet income, FY2023: 386.32M USDNet income, FY2024: 631.51M USDNet income, FY2025: 737.68M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 1.72B USD. Revenue FY2022 2.33B USD. Revenue FY2023 2.88B USD. Revenue FY2024 3.3B USD. Revenue FY2025 3.62B USD. Operating income FY2021 440.9M USD. Operating income FY2022 664.1M USD. Operating income FY2023 767.06M USD. Operating income FY2024 1.01B USD. Operating income FY2025 1.19B USD. Net income FY2021 223.33M USD. Net income FY2022 373.57M USD. Net income FY2023 386.32M USD. Net income FY2024 631.51M USD. Net income FY2025 737.68M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue3.62B USD3.3B USD2.88B USD2.33B USD1.72B USD
Cost of goods sold1.29B USD1.22B USD1.11B USD859.55M USD652.3M USD
Gross profit2.34B USD2.09B USD1.77B USD1.47B USD1.07B USD
Research and development20.09M USD21.5M USD9.44M USD
Selling, general, and administrative1.15B USD1.07B USD1.01B USD798.15M USD622.62M USD
Operating expenses1.15B USD1.08B USD999.04M USD805.58M USD626.18M USD
Interest income43.42M USD107.12M USD27.2M USD23.04M USD
Interest expense493.78M USD366.35M USD386.3M USD288.65M USD175.65M USD
Depreciation and amortization204.12M USD289.51M USD211.94M USD154.22M USD
Operating income1.19B USD1.01B USD767.06M USD664.1M USD440.9M USD
Net income737.68M USD631.51M USD386.32M USD373.57M USD223.33M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
82%
9 beats, 1 miss, 1 met estimate
Average EPS surprise
+9.47%
11 comparable reports
Latest EPS result
0.45
Estimate 0.39 · Beat by 15.71%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.60.490.390.28Q1 '25BeatQ2 '25BeatQ3 '25MetQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Mar 13, 2025: actual 0.36, estimate 0.34, surprise +5.88%, Beat. Q2 2025, reported May 8, 2025: actual 0.55, estimate 0.46, surprise +19.57%, Beat. Q3 2025, reported Aug 13, 2025: actual 0.4, estimate 0.4, surprise 0.00%, Met estimate. Q4 2025, reported Nov 12, 2025: actual 0.38, estimate 0.32, surprise +18.75%, Beat. Q1 2026, reported Mar 12, 2026: actual 0.41, estimate 0.38, surprise +7.89%, Beat. Q2 2026, reported May 7, 2026: actual 0.56, estimate 0.53, surprise +5.66%, Beat. Q3 2026, reported Aug 13, 2026: actual 0.45, estimate 0.389, surprise +15.71%, Beat. Q4 2026, reported Nov 12, 2026: actual —, estimate 0.41, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates212.67M184.7M156.73M128.77MQ1 '25MissQ2 '25MissQ3 '25MissQ4 '25MissQ1 '26MissQ2 '26MissQ3 '26MissQ4 '26Estimate
Q1 2025, reported Mar 13, 2025: actual 136.95M USD, estimate 160.51M USD, surprise -14.68%, Miss. Q2 2025, reported May 8, 2025: actual 160.33M USD, estimate 165.5M USD, surprise -3.12%, Miss. Q3 2025, reported Aug 13, 2025: actual 169.26M USD, estimate 173.03M USD, surprise -2.18%, Miss. Q4 2025, reported Nov 12, 2025: actual 174.05M USD, estimate 174.53M USD, surprise -0.28%, Miss. Q1 2026, reported Mar 12, 2026: actual 166.26M USD, estimate 167.59M USD, surprise -0.80%, Miss. Q2 2026, reported May 7, 2026: actual 192.67M USD, estimate 204.49M USD, surprise -5.78%, Miss. Q3 2026, reported Aug 13, 2026: actual 187.42M USD, estimate 189.62M USD, surprise -1.16%, Miss. Q4 2026, reported Nov 12, 2026: actual —, estimate 194.83M USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$16.75

16.00% upside
Past 12 months12-month forecast

Price history unavailable

High $18.00Average $16.75Low $16.00

Rating distribution

8 ratings
Strong buy00%
Buy338%
Hold450%
Sell113%
Strong sell00%

AFYA peers

ETFs holding AFYA

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research AFYA

research.disclaimer